Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Centrality in the Cross-sectional Network of Depressive Symptom and Metacognitive Variables During COVID-19: Do Central Variables Predict Overall Symptom Reduction From Periods of Strict to Lifted Social Distancing Protocols?

NCT04444713 is registered in ClinicalTrials.gov with Modum Bad as lead sponsor.

NCT NCT04444713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Centrality in the Cross-sectional Network of Depressive Symptom and Metacognitive Variables During COVID-19: Do Central Variables Predict Overall Symptom Reduction From Periods of Strict to Lifted Social Distancing Protocols?
Lead sponsor
Modum Bad
Phase
Observational
Overall status
Unknown status
Start date
June 22, 2020
Completion date
July 13, 2020
Enrollment
10,084 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depressive symptoms, metacognitive variables